|
SPRO Spero Therapeutics Inc 1701108 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-7,203,000.00 |
| Balance Sheet |
|
Current Assets
|
$57,612,000.00 |
|
Assets
|
$59,021,000.00 |
|
Current Liabilities
|
$5,489,000.00 |
|
Liabilities
|
$6,087,000.00 |
|
Equity
|
$52,934,000.00 |
|
Shares Out
|
57891493.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$15,864,000.00 |
| Market Analysis |
Market Cap
|
$69,469,791.60 |
|
Price
|
$1.19 |
|
BVPS
|
0.91 |
|
PB
|
1.32 |
|
EPS
|
-0.13 |
|
PE
|
13.10 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:37 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:35 |
|
| Apr |
May |
Jun |
| 2026-03-26 |
0.53 |
|
|
2026-05-13 |
-0.13 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-0.03 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.13 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view SPRO documents filed with the SEC.
SPRO Filings
Clear
